with H2O and extracted with diethyl ether (3 × 20 mL). The
combined organic phase was washed with brine and dried over
Na2SO4. Filtration, evaporation, and column chromatography on
silica gel (eluent: petroleum ether–ethyl acetate = 50 : 1) afforded
the final product 4.
6.87–6.91 (m, 2H), 2.68–3.00 (m, 4H); 13C NMR (100 MHz,
CDCl3) δ 210.6, 191.9, 165.1 (d, J = 252.1 Hz), 134.2 (d, J =
3.2 Hz), 133.1, 132.8, 132.5, 131.2 (d, J = 9.0 Hz), 129.9,
129.3, 129.2, 129.1, 128.8, 128.6, 128.0, 127.7, 126.9, 115.0 (d,
J = 21.4 Hz), 107.8, 101.2, 29.5, 25.4; MS (EI, m/z): 578 (M+);
IR (ATR, neat, cm−1): 1916, 1648, 1264, 759, 735, 689; HRMS
(EI): m/z calcd for C30H23FOSe2 (M+): 578.0063; Found:
578.0078.
4-Phenyl-4-(phenylselenyl)-2-(2-(phenylselenyl)ethyl)-1-p-tolyl-
buta-2,3-dien-1-one (4a). The reaction of diphenyl diselenide
(187 mg, 0.6 mmol, 1.2 equiv), a solution of n-BuLi in n-hexane
(2.5 M, 0.24 mL, 0.6 mmol, 1.2 equiv), 2a (130 mg, 0.5 mmol,
1.0 equiv), and phenylselenyl bromide 3 (142 mg, 0.6 mmol, 1.2
1-(2-Furanyl)-4-phenyl-4-(phenylselenyl)-2-(2-(phenylselenyl)
ethyl)buta-2,3-dien-1-one (4e). The reaction of diphenyl disele-
nide (187 mg, 0.6 mmol, 1.2 equiv), a solution of n-BuLi in
n-hexane (2.5 M, 0.24 mL, 0.6 mmol, 1.2 equiv), 2d (118 mg,
0.5 mmol, 1.0 equiv), and phenylselenyl bromide 3 (142 mg,
0.6 mmol, 1.2 equiv) in THF (4 mL) afforded 4e (151 mg,
1
equiv) in THF (4 mL) afforded 4a (218 mg, 76%). Liquid. H
NMR (400 MHz, CDCl3) δ 7.66 (d, J = 7.6 Hz, 2H), 7.50 (d, J
= 7.2 Hz, 2H), 7.44 (d, J = 5.6 Hz, 2H), 7.15–7.31 (m, 9H),
7.01–7.09 (m, 4H), 2.69–2.99 (m, 4H), 2.29 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 210.6, 192.9, 142.9, 135.4, 133.0, 132.9,
132.4, 130.0, 129.5, 129.1, 129.0, 128.8, 128.7, 128.3, 127.7,
126.7, 107.7, 100.5, 29.6, 25.4, 21.5; MS (EI, m/z): 574 (M+);
IR (ATR, neat, cm−1): 1916, 1646, 1269, 756, 734, 689; HRMS
(EI): m/z calcd for C31H26OSe2 (M+): 574.0314; Found:
574.0312.
1
55%). Liquid. H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 7.6
Hz, 2H), 7.49 (s, 1H), 7.31–7.42 (m, 7H), 7.18–7.24 (m, 5H),
7.12–7.16 (m, 2H), 6.37–6.38 (m, 1H), 2.70–2.89 (m, 3H),
2.51–2.57 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 208.5,
178.6, 151.6, 146.5, 134.2, 132.7, 132.3, 129.9, 129.3, 129.0,
128.9, 128.8, 128.7, 128.4, 127.7, 126.7, 118.4, 112.0, 107.8,
102.4, 29.3, 25.1; MS (EI, m/z): 550 (M+); IR (ATR, neat,
cm−1): 1919, 1636, 1290, 759, 734, 689; HRMS (EI): m/z calcd
for C28H22O2Se2 (M+): 549.9950; Found: 549.9959.
2-(2-(Butylselenyl)ethyl)-4-phenyl-4-(phenylselenyl)-1-p-tolylbuta-
2,3-dien-1-one (4b). The reaction of di(n-butyl) diselenide
(163 mg, 0.6 mmol, 1.2 equiv), a solution of n-BuLi in n-hexane
(2.5 M, 0.24 mL, 0.6 mmol, 1.2 equiv), 2a (130 mg, 0.5 mmol,
1.0 equiv), and phenylselenyl bromide 3 (142 mg, 0.6 mmol, 1.2
1-Phenyl-1-(phenylselenyl)-3-(2-(phenylselenyl)ethyl)hepta-1,2-
dien-4-one (4f). The reaction of diphenyl diselenide (187 mg,
0.6 mmol, 1.2 equiv), a solution of n-BuLi in n-hexane (2.5 M,
0.24 mL, 0.6 mmol, 1.2 equiv), 2f (106 mg, 0.5 mmol, 1.0
equiv), and phenylselenyl bromide 3 (142 mg, 0.6 mmol, 1.2
1
equiv) in THF (4 mL) afforded 4b (127 mg, 46%). Liquid. H
NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.4 Hz, 2H), 7.52 (d, J
= 7.6 Hz, 2H), 7.19–7.33 (m, 6H), 7.10–7.14 (m, 2H), 7.03 (d, J
= 8.0 Hz, 2H), 2.68–2.84 (m, 2H), 2.53–2.63 (m, 4H), 2.32 (s,
3H), 1.57–1.65 (m, 2H), 1.34–1.42 (m, 2H), 0.89 (t, J = 7.2 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 210.8, 193.1, 143.0, 135.5,
133.0, 132.8, 129.7, 129.1, 128.8, 128.7, 128.7, 128.3, 127.7,
127.6, 107.9, 100.2, 32.5, 30.0, 23.8, 23.0, 21.5, 21.4, 13.6; MS
(EI, m/z): 554 (M+); IR (ATR, neat, cm−1): 1916, 1647, 1268,
759, 736, 689; HRMS (EI): m/z calcd for C29H30OSe2 (M+):
554.0627; Found: 554.0623.
1
equiv) in THF (4 mL) afforded 4f (160 mg, 61%). Liquid. H
NMR (400 MHz, CDCl3) δ 7.60 (d, J = 7.6 Hz, 2H), 7.48 (d, J
= 7.2 Hz, 2H), 7.17–7.40 (m, 11H), 2.72–2.85 (m, 2H),
2.57–2.64 (m, 1H), 2.39–2.49 (m, 3H), 1.48–1.57 (m, 2H), 0.82
(t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 209.4,
199.9, 134.2, 132.8, 132.4, 130.0, 129.3, 129.1, 129.0, 128.8,
128.5, 128.4, 127.5, 126.7, 109.8, 101.8, 41.7, 28.2, 25.3, 17.8,
13.7; MS (EI, m/z): 526 (M+); IR (ATR, neat, cm−1): 1918,
1674, 1439, 1125, 735, 689; HRMS (EI): m/z calcd for
C27H26OSe2 (M+): 526.0314; Found: 526.0318.
1-(4-Methoxyphenyl)-4-phenyl-4-(phenylselenyl)-2-(2-(phenylsel-
enyl)ethyl)buta-2,3-dien-1-one (4c). The reaction of diphenyl dis-
elenide (187 mg, 0.6 mmol, 1.2 equiv), a solution of n-BuLi in
n-hexane (2.5 M, 0.24 mL, 0.6 mmol, 1.2 equiv), 2b (138 mg,
0.5 mmol, 1.0 equiv), and phenylselenyl bromide 3 (142 mg,
0.6 mmol, 1.2 equiv) in THF (4 mL) afforded 4c (201 mg,
2,2-Dimethyl-6-phenyl-6-(phenylselenyl)-4-(2-(phenylselenyl)
ethyl)hexa-4,5-dien-3-one (4g). The reaction of diphenyl disele-
nide (187 mg, 0.6 mmol, 1.2 equiv), a solution of n-BuLi in
n-hexane (2.5 M, 0.24 mL, 0.6 mmol, 1.2 equiv), 2g (113 mg,
0.5 mmol, 1.0 equiv), and phenylselenyl bromide 3 (142 mg,
0.6 mmol, 1.2 equiv) in THF (4 mL) afforded 4g (181 mg,
1
68%). Liquid. H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.8
Hz, 2H), 7.52 (d, J = 7.2 Hz, 2H), 7.43–7.46 (m, 2H), 7.18–7.33
(m, 9H), 7.07–7.11 (m, 2H), 6.70 (d, J = 8.8 Hz, 2H), 3.74 (s,
3H), 2.70–3.00 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 210.2,
191.6, 163.0, 133.0, 132.7, 132.4, 131.1, 130.6, 130.0, 129.6,
129.2, 129.0, 128.7, 128.4, 127.7, 127.6, 126.7, 113.2, 107.4,
100.3, 55.3, 29.8, 25.4; MS (EI, m/z): 590 (M+); IR (ATR, neat,
cm−1): 1916, 1642, 1251, 1025, 757, 735, 690; HRMS (EI): m/z
calcd for C31H26O2Se2 (M+): 590.0263; Found: 590.0272.
1-(4-Fluorophenyl)-4-phenyl-4-(phenylselenyl)-2-(2-(phenylsel-
enyl)ethyl)buta-2,3-dien-1-one (4d). The reaction of diphenyl dis-
elenide (187 mg, 0.6 mmol, 1.2 equiv), a solution of n-BuLi in
n-hexane (2.5 M, 0.24 mL, 0.6 mmol, 1.2 equiv), 2c (132 mg,
0.5 mmol, 1.0 equiv), and phenylselenyl bromide 3 (142 mg,
0.6 mmol, 1.2 equiv) in THF (4 mL) afforded 4d (171 mg,
59%). Liquid. 1H NMR (400 MHz, CDCl3) δ 7.72–7.75 (m,
2H), 7.44–7.51 (m, 4H), 7.19–7.35 (m, 9H), 7.09–7.13 (m, 2H),
1
67%). Liquid. H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 7.6
Hz, 2H), 7.15–7.44 (m, 13H), 2.67–2.82 (m, 2H), 2.56–2.64 (m,
1H), 2.38–2.46 (m, 1H), 1.18 (s, 9H); 13C NMR (100 MHz,
CDCl3) δ 208.0, 205.0, 133.4, 132.7, 132.3, 130.0, 129.5, 129.2,
129.0, 128.8, 128.3, 128.0, 127.6, 126.7, 104.7, 99.8, 44.9,
30.7, 27.4, 25.4; MS (EI, m/z): 540 (M+); IR (ATR, neat, cm−1):
1913, 1663, 1475, 1108, 734, 689; HRMS (EI): m/z calcd for
C28H28OSe2 (M+): 540.0471; Found: 540.0474.
4-(Phenylselenyl)-2-(2-(phenylselenyl)ethyl)-1-p-tolylocta-2,3-
dien-1-one (4h). The reaction of diphenyl diselenide (187 mg,
0.6 mmol, 1.2 equiv), a solution of n-BuLi in n-hexane (2.5 M,
0.24 mL, 0.6 mmol, 1.2 equiv), 2h (120 mg, 0.5 mmol, 1.0
equiv), and phenylselenyl bromide 3 (142 mg, 0.6 mmol, 1.2
1
equiv) in THF (4 mL) afforded 4h (175 mg, 65%). Liquid. H
NMR (400 MHz, CDCl3) δ 7.64 (d, J = 8.0 Hz, 2H), 7.49
Org. Biomol. Chem., 2012, 10, 3705–3714 | 3709
This journal is © The Royal Society of Chemistry 2012